Ruixin Wu

1.2k total citations
17 papers, 855 citations indexed

About

Ruixin Wu is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Ruixin Wu has authored 17 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Rheumatology. Recurrent topics in Ruixin Wu's work include Atherosclerosis and Cardiovascular Diseases (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Ruixin Wu is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Ruixin Wu collaborates with scholars based in Sweden, China and United States. Ruixin Wu's co-authors include Ann‐Kari Lefvert, Johan Frostegård, Ulf dé Fairé, Claes Bergmark, Jesper Swedenborg, Liselotte Schäfer Elinder, Ricardo Giscombe, G. Holm, Jan Nilsson and Yihui Huang and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, American Journal of Obstetrics and Gynecology and Frontiers in Immunology.

In The Last Decade

Ruixin Wu

16 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruixin Wu Sweden 10 511 217 202 187 160 17 855
Simon E. Roselaar United States 7 489 1.0× 68 0.3× 91 0.5× 181 1.0× 222 1.4× 7 812
Federico Calara United States 16 592 1.2× 126 0.6× 156 0.8× 294 1.6× 278 1.7× 18 1.3k
Asheesh K. Dewan United States 7 1.1k 2.1× 236 1.1× 145 0.7× 326 1.7× 333 2.1× 9 1.6k
Erica N. Montano United States 9 438 0.9× 85 0.4× 43 0.2× 204 1.1× 131 0.8× 13 662
David J. Hunter United States 10 241 0.5× 68 0.3× 41 0.2× 597 3.2× 67 0.4× 12 982
Sylvie Goulinet France 11 106 0.2× 52 0.2× 135 0.7× 304 1.6× 414 2.6× 17 1.1k
Prashant S. Patole Germany 12 678 1.3× 334 1.5× 21 0.1× 244 1.3× 138 0.9× 13 1.1k
Gülseren Çimşit Türkiye 12 240 0.5× 200 0.9× 28 0.1× 110 0.6× 40 0.3× 20 598
Chieh‐Yu Shen Taiwan 17 287 0.6× 219 1.0× 18 0.1× 352 1.9× 113 0.7× 38 945
M R Elstad United States 10 359 0.7× 41 0.2× 55 0.3× 238 1.3× 177 1.1× 10 1.2k

Countries citing papers authored by Ruixin Wu

Since Specialization
Citations

This map shows the geographic impact of Ruixin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruixin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruixin Wu more than expected).

Fields of papers citing papers by Ruixin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruixin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruixin Wu. The network helps show where Ruixin Wu may publish in the future.

Co-authorship network of co-authors of Ruixin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruixin Wu. A scholar is included among the top collaborators of Ruixin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruixin Wu. Ruixin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Zhang, Junqian, Xiaobo Zhang, Ruixin Wu, & Changsheng Dong. (2025). Unveiling purine metabolism dysregulation orchestrated immunosuppression in advanced pancreatic cancer and concentrating on the central role of NT5E. Frontiers in Immunology. 16. 1569088–1569088. 2 indexed citations
3.
Luo, Feiyang, Qizhi Yao, Yanan Hao, et al.. (2025). Functional avidity enhancement of a T-cell receptor targeting the KRASG12D cancer neoantigen. Cellular Immunology. 414. 104999–104999. 1 indexed citations
4.
Wu, Ruixin, Ruiqin Han, Satoru Kawakita, et al.. (2024). The role of KLF5 in gut microbiota and lung adenocarcinoma: unveiling programmed cell death pathways and prognostic biomarkers. Discover Oncology. 15(1). 408–408. 2 indexed citations
5.
Yan, Min, Ruixin Wu, Fu Han, et al.. (2024). Integrated analysis of single-cell and bulk RNA sequencing data reveals the association between hypoxic tumor cells and exhausted T cells in predicting immune therapy response. Computers in Biology and Medicine. 171. 108179–108179. 2 indexed citations
6.
7.
Frostegård, Johan, et al.. (2003). Antibodies against platelet-activating factor and platelet-activating factor–like lipids are raised in women with primary recurrent abortion. American Journal of Obstetrics and Gynecology. 189(2). 568–573. 1 indexed citations
8.
9.
Sherer, Yaniv, Ruixin Wu, Ilan Krause, James B. Peter, & Yehuda Shoenfeld. (2001). Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparations. Lupus. 10(8). 568–570. 12 indexed citations
10.
Frostegård, Johan, et al.. (2000). Proinflammatory cytokines in atherosclerotic plaques are induced by LysoPC AND PAF-like lipids. Atherosclerosis. 151(1). 261–261. 1 indexed citations
11.
Wu, Ruixin, Elisabet Svenungsson, Iva Gunnarsson, et al.. (1999). Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and β2-glycoprotein I (β2-GPI) in systemic lupus erythematosus. Clinical & Experimental Immunology. 115(3). 561–566. 31 indexed citations
12.
Wu, Ruixin, Carola Lemne, Ulf dé Fairé, & Johan Frostegård. (1999). Antibodies to platelet‐activating factor are associated with borderline hypertension, early atherosclerosis and the metabolic syndrome. Journal of Internal Medicine. 246(4). 389–397. 15 indexed citations
13.
Wu, Ruixin, Elisabet Svenungsson, Iva Gunnarsson, et al.. (1999). Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE. Lupus. 8(2). 142–150. 41 indexed citations
14.
Huang, Yihui, Liselotte Schäfer Elinder, Ruixin Wu, Hans‐Erik Claesson, & Johan Frostegård. (1999). Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clinical & Experimental Immunology. 116(2). 326–331. 156 indexed citations
15.
Bergmark, Claes, Ruixin Wu, Ulf dé Fairé, Ann‐Kari Lefvert, & Jesper Swedenborg. (1995). Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDL. Arteriosclerosis Thrombosis and Vascular Biology. 15(4). 441–445. 214 indexed citations
16.
Wu, Ruixin & Ann‐Kari Lefvert. (1995). Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. Clinical & Experimental Immunology. 102(1). 174–180. 66 indexed citations
17.
Frostegård, Johan, Ruixin Wu, Ricardo Giscombe, et al.. (1992). Induction of T-cell activation by oxidized low density lipoprotein.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 12(4). 461–467. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon E. Roselaar Breakdown of academic impact, for papers by Federico Calara Breakdown of academic impact, for papers by Asheesh K. Dewan Breakdown of academic impact, for papers by Erica N. Montano Breakdown of academic impact, for papers by David J. Hunter Breakdown of academic impact, for papers by Sylvie Goulinet Breakdown of academic impact, for papers by Prashant S. Patole Breakdown of academic impact, for papers by Gülseren Çimşit Breakdown of academic impact, for papers by Chieh‐Yu Shen Breakdown of academic impact, for papers by M R Elstad
Rankless by CCL
2026